Amphetamine use and its associations with antiretroviral adherence and viral load among sexual minority men and transgender women living with HIV

References

• Andresen-Streichert, H., Müller, A., Glahn, A., Skopp, G., & Sterneck, M. (2018). Alcohol biomarkers in clinical and forensic contexts. Deutsches Ärzteblatt International, 115(18), 309–315. https://doi.org/10.3238/arztebl.2018.0309
   PubMed Web of Science ®Google Scholar
• Bandura, A. (2005). Guide for constructing self-efficacy scales. In Self-efficacy beliefs of adolescents (pp. 307–337). Information Age Publishing. https://doi.org/10.1017/CBO9781107415324.004
   Google Scholar
• Bangsberg, D. R. (2001). Comparing objective measures of adherence to HIV antiretroviral therapy: Electronic medication monitors and unannounced pill counts. AIDS and Behavior, 5(3), 275–281. https://doi.org/10.1023/A:1011396711486
   Google Scholar
• Carrico, A. W. (2011). Substance use and HIV disease progression in the HAART era: Implications for the primary prevention of HIV. Life Sciences, 88(21–22), 940–947. https://doi.org/10.1016/j.lfs.2010.10.002
   PubMed Web of Science ®Google Scholar
• Carrico, A. W., Neilands, T. B., Dilworth, S. E., Evans, J. L., Gόmez, W., Jain, J. P., Gandhi, M., Shoptaw, S., Horvath, K. J., Coffin, L., Discepola, M. V., Andrews, R., Woods, W. J., Feaster, D. J., & Moskowitz, J. T. (2019). Randomized controlled trial of a positive affect intervention to reduce HIV viral load among sexual minority men who use methamphetamine. Journal of the International AIDS Society, 22(12). https://doi.org/10.1002/jia2.25436
   Google Scholar
• Carrico, A. W., Woolf-King, S. E., Neilands, T. B., Dilworth, S. E., & Johnson, M. O. (2014). Stimulant use and HIV disease management among men in same-sex relationships. Drug and Alcohol Dependence, 139, 174–177. https://doi.org/10.1016/j.drugalcdep.2014.03.025
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2019). Diagnoses of HIV infection in the United States and dependent areas 2019: National profile. https://www.Cdc.Gov/Hiv/Library/Reports/Hiv-Surveillance/Vol-32/Content/National-Profile.Html#Diagnoses
   Google Scholar
• Cook, R. L., Zhou, Z., Kelso-Chichetto, N. E., Janelle, J., Morano, J. P., Somboonwit, C., Carter, W., Ibanez, G. E., Ennis, N., Cook, C. L., Cohen, R. A., Brumback, B., & Bryant, K. (2017). Alcohol consumption patterns and HIV viral suppression among persons receiving HIV care in Florida: An observational study. Addiction Science & Clinical Practice, 12(1). https://doi.org/10.1186/s13722-017-0090-0
   Google Scholar
• Crepaz, N., Tang, T., Marks, G., Mugavero, M. J., Espinoza, L., & Hall, H. I. (2016). Durable viral suppression and transmission risk potential among persons with diagnosed HIV infection: United States, 2012-2013. Clinical Infectious Diseases, 63(7), 976–983. https://doi.org/10.1093/cid/ciw418
   PubMed Web of Science ®Google Scholar
• Erlen, J. A., Cha, E. S., Kim, K. H., Caruthers, D., & Sereika, S. M. (2010). The HIV medication taking self-efficacy scale: Psychometric evaluation. Journal of Advanced Nursing, 66(11), 2560–2572. https://doi.org/10.1111/j.1365-2648.2010.05400.x
   PubMed Web of Science ®Google Scholar
• Glynn, T. R., Safren, S. A., Carrico, A. W., Mendez, N. A., Duthely, L. M., Dale, S. K., Jones, D. L., Feaster, D. J., & Rodriguez, A. E. (2019). High levels of syndemics and their association with adherence, viral non-suppression, and biobehavioral transmission risk in Miami, a U.S. city with an HIV/AIDS epidemic. AIDS and Behavior, 23(11), 2956–2965. https://doi.org/10.1007/s10461-019-02619-0
   PubMed Web of Science ®Google Scholar
• Hayes, A. F. (2012). PROCESS: A versatile computational tool for observed variable mediation, moderation, and conditional process modeling 1. http://www.afhayes.com/
   Google Scholar
• Kalichman, S. C., Amaral, C. M., Cherry, C., Flanagan, J., Pope, H., Eaton, L., Kalichman, M. O., Cain, D., Detorio, M., Caliendo, A., & Schinazi, R. F. (2008). Monitoring medication adherence by unannounced pill counts conducted by telephone: Reliability and criterion-related validity. HIV Clinical Trials, 9(5), 298–308. https://doi.org/10.1310/hct0905-298
   PubMed Web of Science ®Google Scholar
• Kapadia, F., Vlahov, D., Donahoe, R. M., & Friedland, G. (2005). The role of substance abuse in HIV disease progression: Reconciling differences from laboratory and epidemiologic investigations. Clinical Infectious Diseases, 41(7), 1027–1034. https://academic.oup.com/cid/article/41/7/1027/307109; https://doi.org/10.1086/433175
   PubMed Web of Science ®Google Scholar
• Lowe, J. M., Mcdonell, M. G., Leickly, E., Angelo, F. A., Vilardaga, R., Mcpherson, S., Srebnik, D., Roll, J., & Ries, R. K. (2015). Determining ethyl glucuronide cutoffs when detecting self-reported alcohol use in addiction treatment patients. Alcoholism: Clinical and Experimental Research, 39(5), 905–910. https://doi.org/10.1111/acer.12699
   PubMed Web of Science ®Google Scholar
• Meyers-Pantele, S. A., Rendina, H. J., Talan, A. J., Shalhav, O., Lammert, S., & Horvath, K. J. (2021). Characterizing substance use typologies and their association with HIV viral load outcomes: A latent class analysis among sexual minority men living with HIV. Drug and Alcohol Dependence, 227, 108928. https://doi.org/10.1016/j.drugalcdep.2021.108928
   PubMed Web of Science ®Google Scholar
• Mgbere, O., Khuwaja, S., Bell, T. K., Rodriguez-Barradas, M. C., Arafat, R., Essien, E. J., Singh, M., Aguilar, J., & Roland, E. (2015). System and patient barriers to care among people living with HIV/AIDS in Houston/Harris County, Texas. Journal of the International Association of Providers of AIDS Care (JIAPAC), 14(6), 505–515. https://doi.org/10.1177/2325957414539045
   PubMedGoogle Scholar
• Montgomery, L., Bagot, K., Brown, J. L., & Haeny, A. M. (2019). The association between marijuana use and HIV continuum of care outcomes: A systematic review. Current HIV/AIDS Reports, 16(1), 17–28. https://doi.org/10.1007/s11904-019-00422-z
   PubMed Web of Science ®Google Scholar
• Okafor, C. N., Zhou, Z., Burrell Ii, L. E., Kelso, N. E., Whitehead, N. E., Harman, J. S., Cook, C. L., & Cook, R. L. (2017). Marijuana use and viral suppression in persons receiving medical care for HIV-infection. The American Journal of Drug and Alcohol Abuse, 43(1), 103–110. https://doi.org/10.1080/00952990.2016.1191505
   PubMed Web of Science ®Google Scholar
• Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401. https://doi.org/10.1177/014662167700100306
   Web of Science ®Google Scholar
• Sullivan, P. S., Woodyatt, C., Koski, C., Pembleton, E., McGuinness, P., Taussig, P., Ricca, A., Luisi, N., Mokotoff, E., Benbow, N., & Castel, A. D. (2020). A data visualization and dissemination resource to support HIV prevention and care at the local level: Analysis and uses of the AIDSVu Public Data Resource. Journal of Medical Internet Research, 22(10), e23173. https://doi.org/10.2196/23173
   PubMed Web of Science ®Google Scholar
• Wu, E. S., Metzger, D. S., Lynch, K. G., & Douglas, S. D. (2011). Association between alcohol use and HIV viral load. JAIDS Journal of Acquired Immune Deficiency Syndromes, 56(5), e129–e130. https://doi.org/10.1097/QAI.0B013E31820DC1C8
   PubMed Web of Science ®Google Scholar
• Wurst, F. M., Alling, C., Aradottir, S., Pragst, F., Allen, J. P., Weinmann, W., Marmillot, P., Ghosh, P., Lakshman, R., Skipper, G. E., Neumann, T., Spies, C., Javors, M., Johnson, B. A., Ait-Daoud, N., Akhtar, F., Roache, J. D., & Litten, R. (2005). Emerging biomarkers: New directions and clinical applications. Alcoholism: Clinical & Experimental Research, 29(3), 465–473. https://doi.org/10.1097/01.ALC.0000156082.08248.AB
   PubMed Web of Science ®Google Scholar